ANNEXON BIOSCIENCES
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. The company’s first product... candidate, ANX005, is a full-length monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. The company’s second product candidate, ANX007, is a monoclonal antibody Fab formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. Annexon is advancing its current programs while evaluating additional orphan and large market indications. Annexon is deploying a disciplined, biomarker-driven development strategy designed to establish that its product candidates are engaging the target at a well-tolerated therapeutic dose in the intended patient tissue.
ANNEXON BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Life Science Therapeutics
Founded:
2011-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.annexonbio.com
Total Employee:
101+
Status:
Active
Contact:
(650)822-5500
Email Addresses:
[email protected]
Total Funding:
384 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Kezar Life Sciences
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Satter Investment Management
Satter Investment Management investment in Post-IPO Equity - Annexon Biosciences
Fairmount Funds Management
Fairmount Funds Management investment in Post-IPO Equity - Annexon Biosciences
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - Annexon Biosciences
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Annexon Biosciences
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Annexon Biosciences
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Annexon Biosciences
Redmile Group
Redmile Group investment in Post-IPO Equity - Annexon Biosciences
Satter Investment Management
Satter Investment Management investment in Series C - Annexon Biosciences
New Enterprise Associates
New Enterprise Associates investment in Series C - Annexon Biosciences
Adage Capital Management
Adage Capital Management investment in Series C - Annexon Biosciences
Official Site Inspections
http://www.annexonbio.com Semrush global rank: 7.31 M Semrush visits lastest month: 528
- Host name: 41.102.145.34.bc.googleusercontent.com
- IP address: 34.145.102.41
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
